Martin Shkreli Sells Remaining Stake In KaloBios
Martin Shkreli sold his remaining stake in KaloBios Pharmaceuticals Inc., the rare disease biopharmaceutical company that he helmed for a month prior to his arrest, ending a brief, tumultuous relationship with...To view the full article, register now.
Already a subscriber? Click here to view full article